Abiopharma

Reisin Richard 🟢 acquired 6.9K shares of Green Thumb Industries Inc. (GTII/GTBIF) Transaction Date: Sep 01, 2025 | Filing ID: 023525

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 6-K - Universe Pharmaceuticals INC Filed: 2025-09-03 AccNo: 0001213900-25-084040 Size: 52 KB

Goldman Jeffrey H 🟢 acquired 6.5K shares of Green Thumb Industries Inc. (GTII/GTBIF) Transaction Date: Sep 01, 2025 | Filing ID: 023520

Buchan Hannah Scofield 🟢 acquired 5.0K shares of Green Thumb Industries Inc. (GTII/GTBIF) Transaction Date: Sep 01, 2025 | Filing ID: 023518

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

New Form 6-K - Apollomics Inc. Filed: 2025-09-03 AccNo: 0001193125-25-194953 Size: 194 KB

Vandervoort Adam C 🟡 adjusted position in 5.9K shares (3 derivative) of Teladoc Health, Inc. (TDOC) at $7.58 Transaction Date: Aug 29, 2025 | Filing ID: 000107

Longeveron - Longeveron® Announces Key Leadership Updates

Equillium - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

Director MILANO VINCENT 🟢 acquired 676 shares of BIOCRYST PHARMACEUTICALS INC (BCRX) at $8.31 Transaction Date: Aug 29, 2025 | Filing ID: 000003

New Form 8-K - Galera Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0001193125-25-194948 Size: 135 KB Item 1.01: Entry into a Material Definitive Agreement